Remi Gaston-Dreyfus

Insider Reports History

Identity
Location
Paris, France
SEC record
Reporting signature
/s/ Remi Gaston-Dreyfus
SEC evidence
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Remi Gaston-Dreyfus:

Form 4 holding Director, 10%+ Owner

Bionik Laboratories Corp.

Security class
Common Stock, par value $0.001 per share
Shares / value
4,917,749
Estimated value
$2,950,649
Report date
13 Jun 2023
Price
$0.6000
Ownership
Shares held through GD Holdings and Lombard International Assurance SA
Form 4 holding Director, 10%+ Owner

Bionik Laboratories Corp.

Security class
Common Stock, par value $0.001 per share
Shares / value
61,256
Estimated value
$36,754
Report date
13 Jun 2023
Price
$0.6000
Ownership
Direct

Insider Reports Filed by Remi Gaston-Dreyfus

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .